Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide. (Q51040534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

interstitial lung disease

28 January 2020

main subject

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Fiona Pearce

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Abhishek Abhishek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ramin Yazdani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Marian Regan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ken Lim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Richard Hubbard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

12 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1099-1104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

Changes in causes of death in systemic sclerosis, 1972-2002

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Cyclophosphamide versus placebo in scleroderma lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Interstitial lung disease in systemic sclerosis: a simple staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Low-dose intravenous cyclophosphamide in systemic sclerosis: a preliminary safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Clinical trials and rare diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1734-1

Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results

21 January 2018

1 reference

12 December 2020

Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.

1 reference

12 December 2020

Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.

1 reference

12 December 2020

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

12 December 2020

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

12 December 2020

De Testimonio: on the evidence for decisions about the use of therapeutic interventions.

1 reference

12 December 2020

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

1 reference

12 December 2020

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

1 reference

12 December 2020

Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases

1 reference

12 December 2020

A long-term prospective randomized controlled study of non-specific interstitial pneumonia (NSIP) treatment in scleroderma

1 reference

12 December 2020

Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase

1 reference

12 December 2020

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

12 December 2020

A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease

1 reference

12 December 2020

Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.

1 reference

12 December 2020

10.1007/S10067-011-1734-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484227%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference